• Ann Pharmacother · Dec 2000

    Bayesian approach to control of amikacin serum concentrations in critically ill patients with sepsis.

    • G Lugo-Goytia and G Castañeda-Hernández.
    • Escuela Superior de Medicina del Instituto Politécnico Nacional, Unidad de Posgrado e Investigación, México, DF. lugogoi@comunica.com.mx
    • Ann Pharmacother. 2000 Dec 1;34(12):1389-94.

    ObjectiveTo compare the predictive performance of a Bayesian program incorporating a population model with and without severity of illness covariates in intensive care unit (ICU) patients with sepsis.DesignThe clinical, physiologic, and pharmacokinetic data of 62 patients with sepsis admitted to a tertiary-care center were analyzed retrospectively. The patients were randomly assigned to a active group and a validation group. The model was developed using a three-step approach involving Bayesian estimation of pharmacokinetic parameters, selection of covariates by principal component analysis, and final selection of covariates by stepwise multiple linear regression. The predictive performance of this model was tested in patients from the validation group and compared with that of a general population model without covariates.ResultsRegression analysis revealed that the Acute Physiologic and Chronic Health Evaluation (APACHE II) score was the most important determinant for amikacin volume of distribution (1.5 L/kg, APACHE II; r2 = 0.77). For amikacin clearance (CIamik), creatinine clearance (CIcr), positive end-expiratory pressure (PEEP), and use of catecholamines (CAT) were the most important predictors (CIamik = 44.5 + 0.67 CIcr - 1.29 PEEP - 8.34 CAT; r2 = 0.72). The relative mean error (deltaME) and root mean-square error (deltaRMSE) (95% CI) were -0.62 (-1.2 to 0.01) and 3.78 (2.3 to 4.8) mg/L, respectively. Since the 95% CI for deltaRMSE did not include zero, it appears that the model with covariates is significantly improved in terms of precision.ConclusionsOur results show that, in ICU patients treated with amikacin, it is relevant to consider covariates related to pathophysiologic status and therapeutic measures. Application of a Bayesian program allows improved control of the pharmacokinetic parameters in patients who exhibit rapidly changing physiologic conditions.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.